These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 38603446)
1. Simulation modeling assessment and improvement of a COVID-19 mass vaccination center operations. Jerbi A; Masmoudi F Simulation; 2023 Jun; 99(6):553-572. PubMed ID: 38603446 [TBL] [Abstract][Full Text] [Related]
2. Developing an efficient scheduling template of a chemotherapy treatment unit: A case study. Ahmed Z; Elmekkawy T; Bates S Australas Med J; 2011; 4(10):575-88. PubMed ID: 23386870 [TBL] [Abstract][Full Text] [Related]
3. A Drive-through Simulation Tool for Mass Vaccination during COVID-19 Pandemic. Asgary A; Najafabadi MM; Karsseboom R; Wu J Healthcare (Basel); 2020 Nov; 8(4):. PubMed ID: 33182336 [TBL] [Abstract][Full Text] [Related]
4. Optimizing planning and design of COVID-19 drive-through mass vaccination clinics by simulation. Asgary A; Najafabadi MM; Wendel SK; Resnick-Ault D; Zane RD; Wu J Health Technol (Berl); 2021; 11(6):1359-1368. PubMed ID: 34631358 [TBL] [Abstract][Full Text] [Related]
5. Identification of Key Factors for Optimized Health Care Services: Protocol for a Multiphase Study of the Dubai Vaccination Campaign. Faroun H; Zary N; Baqer K; Alkhaja F; Gad K; Alameddine M; Al Suwaidi H JMIR Res Protoc; 2023 Apr; 12():e42278. PubMed ID: 36541889 [TBL] [Abstract][Full Text] [Related]
6. Simulating a Hockey Hub COVID-19 Mass Vaccination Facility. Asgary A; Blue H; Cronemberger F; Ni M Healthcare (Basel); 2022 May; 10(5):. PubMed ID: 35627980 [TBL] [Abstract][Full Text] [Related]
7. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas. Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557 [TBL] [Abstract][Full Text] [Related]
8. Strategies used to meet the challenges of mass COVID-19 vaccination by the pharmacy department in a large academic medical center. Li Q; Norman S; Guthrie P; Gachoya J; Sebakijje J; Leftridge Z; Willis CG; Kishore A; Breakenridge M; Spence C Am J Health Syst Pharm; 2021 Sep; 78(18):1724-1731. PubMed ID: 33895789 [TBL] [Abstract][Full Text] [Related]
9. Modeling the public health response to bioterrorism: using discrete event simulation to design antibiotic distribution centers. Hupert N; Mushlin AI; Callahan MA Med Decis Making; 2002; 22(5 Suppl):S17-25. PubMed ID: 12369227 [TBL] [Abstract][Full Text] [Related]
10. Discrete-event simulation study of a COVID-19 mass vaccination centre. Sala F; D'Urso G; Giardini C Int J Med Inform; 2023 Feb; 170():104940. PubMed ID: 36495700 [TBL] [Abstract][Full Text] [Related]
11. Public health impact of delaying second dose of BNT162b2 or mRNA-1273 covid-19 vaccine: simulation agent based modeling study. Romero-Brufau S; Chopra A; Ryu AJ; Gel E; Raskar R; Kremers W; Anderson KS; Subramanian J; Krishnamurthy B; Singh A; Pasupathy K; Dong Y; O'Horo JC; Wilson WR; Mitchell O; Kingsley TC BMJ; 2021 May; 373():n1087. PubMed ID: 33980718 [TBL] [Abstract][Full Text] [Related]
12. A new vaccine supply chain network under COVID-19 conditions considering system dynamic: Artificial intelligence algorithms. Kamran MA; Kia R; Goodarzian F; Ghasemi P Socioecon Plann Sci; 2023 Feb; 85():101378. PubMed ID: 35966449 [TBL] [Abstract][Full Text] [Related]
13. Identifying health centers in areas with low COVID-19 vaccination rates & high rates of vaccine hesitancy. Topmiller M; Carrozza M; McCann J; Rankin J Ann Fam Med; 2022 Apr; 20(20 Suppl 1):. PubMed ID: 36706265 [TBL] [Abstract][Full Text] [Related]
14. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial. Akova M; Unal S Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629 [TBL] [Abstract][Full Text] [Related]
15. Has vaccination alleviated the strain on hospitals due to COVID-19? A combined difference-in-difference and simulation approach. Grøsland M; Larsen VB; Telle K; Gjefsen HM BMC Health Serv Res; 2022 Sep; 22(1):1183. PubMed ID: 36131346 [TBL] [Abstract][Full Text] [Related]
16. Application of the "immunization islands" model to improve quality, efficiency and safety of a COVID-19 mass vaccination site. Signorelli C; Odone A; Gianfredi V; Capraro M; Kacerik E; Chiecca G; Scardoni A; Minerva M; Mantecca R; Musarò P; Brazzoli P; Basteri P; Bertini B; Esposti F; Ferri C; Alberti VA; Gastaldi G Ann Ig; 2021; 33(5):499-512. PubMed ID: 34113956 [TBL] [Abstract][Full Text] [Related]
17. Challenges and Opportunities of Mass Vaccination Centers in COVID-19 Times: A Rapid Review of Literature. Gianfredi V; Pennisi F; Lume A; Ricciardi GE; Minerva M; Riccò M; Odone A; Signorelli C Vaccines (Basel); 2021 Jun; 9(6):. PubMed ID: 34205891 [TBL] [Abstract][Full Text] [Related]
18. Invasive meningococcal disease epidemiology and control measures: a framework for evaluation. Caro JJ; Möller J; Getsios D; Coudeville L; El-Hadi W; Chevat C; Nguyen VH; Caro I BMC Public Health; 2007 Jun; 7():130. PubMed ID: 17603880 [TBL] [Abstract][Full Text] [Related]
19. [VACCINATION: HUMAN RIGHT OR DUTY]. Mernyk A; Yaroshenko O; Inshyn M; Lukianov D; Hyliaka O Georgian Med News; 2021 Jun; (315):135-140. PubMed ID: 34365440 [TBL] [Abstract][Full Text] [Related]
20. Enhancement of Intra-hospital patient transfer in medical center hospital using discrete event system simulation. Meephu E; Arwatchananukul S; Aunsri N PLoS One; 2023; 18(4):e0282592. PubMed ID: 37068093 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]